Persistent JNK activation may be largely responsible for the neuronal insulin resistance typical of AD, as JNK can confer an inhibitory phosphorylation on insulin receptor substrate-1 (IRS-1), a mediator of the insulin signaling pathway [8,9,10]. Here, IRS1 is linked to Insulin resistance.